Fig. 8
From: Promising upshot of silver nanoparticles primed from Gracilaria crassa against bacterial pathogens
Antibacterial activity of AgNP’s. Zone of inhibition of silver nanoparticles against a Escherichia coli, b Proteus mirabilis, c Bacillus subtilis, d Pseudomonas aeruginosa; [T1-(20 µg/ml of AgNP’s) and T2 (40 µg/ml of AgNP’s); Standard (Std-Streptomycin sulphate 20 µg/ml)].